IP Verse

Il 2rbeta Selective Agonists In Combination With An Anti Ctla 4 Antibody Or An An Anti Pd 1 Antibody - EP3134123

PATENT ANALYSIS

Patent Details

Grant Date
Feb 17, 2021
Company
NEKTAR THERAPEUTICS
Oppositions

GREINER, ELISABETH

More patents of Nektar Therapeutics

EP3134123

EP2453962

EP3094331

Want to monitor this patent?

Feel free to send us a message here and we will get back to you